GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma

BACKGROUND: Meningiomas are the most common primary intracranial tumours. They are classified as grade I, II, and III based on their histopathological features. While most meningiomas can be managed by surgery alone, adjuvant treatment may be required in case of recurrent, or high-grade tumours. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Negroni, Caterina, Hilton, David A., Ercolano, Emanuela, Adams, Claire L., Kurian, Kathreena M., Baiz, Daniele, Hanemann, C.Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452696/
https://www.ncbi.nlm.nih.gov/pubmed/32810829
http://dx.doi.org/10.1016/j.ebiom.2020.102941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452696/
https://www.ncbi.nlm.nih.gov/pubmed/32810829
http://dx.doi.org/10.1016/j.ebiom.2020.102941

Ejemplares similares